PB 51 of 2014
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2014
(No. 7)
National Health Act 1953
I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953.
Dated      27 June                                            2014
 
 
 
 
 
 
 
 
 
 
 
PAUL CREECH
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Listing of Pharmaceutical                            Benefits) Amendment Instrument 2014 (No. 7).
            (2)        This Instrument may also be cited as PB 51 of 2014.
2          Commencement
This Instrument commences on 1 July 2014.
3          Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)
            Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).
Schedule 1     Amendments
[1]           Schedule 1, entry for Methadone in each of the forms: Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL; and Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 1 L
omit from the column headed “Brand”:         Sigma   substitute:             Aspen